NEKTAR THERAPEUTICS's ticker is NKTR and the CUSIP is 640268108. A total of 155 filers reported holding NEKTAR THERAPEUTICS in Q1 2015. The put-call ratio across all filers is 0.53 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2016 | $823,000 | +32.3% | 59,876 | +65.0% | 0.00% | 0.0% |
| Q4 2015 | $622,000 | -2.2% | 36,290 | -28.6% | 0.00% | 0.0% |
| Q2 2015 | $636,000 | +3247.4% | 50,800 | +2904.1% | 0.00% | – |
| Q1 2015 | $19,000 | -99.0% | 1,691 | -98.6% | 0.00% | -100.0% |
| Q4 2014 | $1,829,000 | +135.7% | 119,091 | +85.2% | 0.00% | +200.0% |
| Q3 2014 | $776,000 | +42.4% | 64,300 | +26.6% | 0.00% | 0.0% |
| Q2 2014 | $545,000 | +51.0% | 50,800 | +47.1% | 0.00% | 0.0% |
| Q3 2013 | $361,000 | +27.6% | 34,532 | +40.8% | 0.00% | 0.0% |
| Q2 2013 | $283,000 | – | 24,526 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Rhenman & Partners Asset Management AB | 1,350,000 | $22,950,000 | 1.87% |
| MAVERICK CAPITAL LTD | 6,655,625 | $113,146,000 | 1.81% |
| Camber Capital Management LP | 2,500,000 | $42,500,000 | 1.49% |
| Bellevue Group AG | 3,866,258 | $65,726,000 | 0.75% |
| Adero Partners, LLC | 51,500 | $876,000 | 0.75% |
| Goodman Financial Corp | 108,342 | $1,842,000 | 0.64% |
| CM Management, LLC | 35,000 | $595,000 | 0.55% |
| OSTERWEIS CAPITAL MANAGEMENT INC | 424,504 | $7,217,000 | 0.43% |
| RICE HALL JAMES & ASSOCIATES, LLC | 568,379 | $9,662,000 | 0.34% |
| Burleson & Company, LLC | 107,736 | $1,832,000 | 0.32% |